The Daily Delta - Canadian AML & Financial Crime News - September 15, 2026
The Daily Delta

The Daily Delta - Canadian AML & Financial Crime News
September 15, 2026

Featured
International Consortium of Investigative Journalists
ICIJ reports that ICBC’s London branch transferred US$1.3 billion for Huawei in February 2019, just days after U.S. prosecutors indicted the company on fraud, sanctions and other charges. Confidential bank records show ICBC London had agreed to suspend business with Huawei pending further review, but the transfer was approved by the bank’s Beijing headquarters and executed over a weekend before the London compliance team was informed. An internal investigation later found that staff had bypassed ordinary controls and acted under pressure from Huawei and head office, with ICBC’s money laundering reporting officer raising concerns that the funds may have been moved to avoid potential asset freezes, although the transaction itself was not illegal. The broader ICIJ investigation says ICBC London repeatedly relaxed or bypassed internal AML controls for politically connected Chinese clients despite objections from compliance staff.
Read more →
Key Developments

Independent AML Effectiveness Reviews
AlphaDelta helps Canadian reporting entities complete required two-year AML effectiveness reviews that are practical, defensible, and aligned to FINTRAC expectations.

Every review includes a 90-day findings clarification session and our 12-month FINTRAC examination support commitment.
Get the weekly recap of the developments shaping AML, sanctions, fraud, and financial crime compliance. Add The Weekly Alpha to your email subscription →
Important Disclosure

The Daily Delta is a curated news briefing produced by AlphaDelta Advisory Group for informational purposes only. It is designed to help readers identify relevant regulatory, enforcement, financial crime, and compliance developments and to direct readers to the original source materials.

Article titles, publisher names, and source links are provided for attribution and reference. Summaries are prepared in AlphaDelta’s own wording, including through the use of automated tools, to provide brief, non-comprehensive descriptions of selected developments. They are not intended to reproduce, replace, or serve as a substitute for the original articles, publications, regulatory guidance, or source materials.

Summaries may omit context, nuance, limitations, author views, subsequent updates, or other information contained in the original source. Readers should review the linked source materials directly before making compliance, legal, operational, policy, or business decisions.

AlphaDelta does not verify, endorse, or guarantee the accuracy, completeness, availability, or timeliness of third-party content referenced in this briefing. All third-party content, trademarks, article titles, publisher names, and related rights remain the property of their respective owners. Reference to third-party materials does not imply endorsement, affiliation, sponsorship, or approval by the original publisher or issuing authority.

If a rights holder believes any reference, summary, or link should be modified or removed, they may contact AlphaDelta Advisory Group at info@alphadeltaadvisory.com for review.
© 2026 AlphaDelta Enterprises Inc. All rights reserved.

When was your last AML effectiveness review?

FINTRAC requires reporting entities to carry out and document an effectiveness review at least every two years.

If your next review is due or approaching, contact AlphaDelta today.
BOOK A REVIEW
© 2026 AlphaDelta Enterprises Inc., operating as AlphaDelta Advisory Group. All rights reserved. Canada.